Selective CDK2 Inhibitor Undergoes Investigation in CCNE1-High Tumors OncLive, 17 Apr 2023 Breast Cancer Preclinical data have demonstrated activity of a novel, small molecule CDK2 inhibitor INCB123667 in CDK2/cyclin…